Neutrophil‑to‑lymphocyte ratio and risk of disease progression in patients with nivolumab‑treated unresectable or recurrent gastric cancer
中性粒细胞与淋巴细胞比值与接受纳武利尤单抗治疗的不可切除或复发性胃癌患者的疾病进展风险
期刊:Oncology Letters
影响因子:2.2
doi:10.3892/ol.2024.14766
Hayashi, Hirokatsu; Yasufuku, Itaru; Sato, Yuta; Fujibayashi, Seito; Chikaishi, Wakana; Endo, Masahide; Horaguchi, Takeshi; Yokoi, Ryoma; Matsumoto, Keita; Kuno, Masashi; Sengoku, Yuki; Fukada, Masahiro; Asai, Ryuichi; Tajima, Jesse Yu; Makiyama, Akitaka; Kiyama, Shigeru; Tanaka, Yoshihiro; Murase, Katsutoshi; Ishihara, Takuma; Matsuhashi, Nobuhisa